Patient, target, device, and program selection for DBS in Parkinson's disease: advancing toward precision care

Aparna Wagle Shukla1, Manuel Bange2, Muthuraman Muthuraman2,3

  • 1Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, USA. aparna.shukla@neurology.ufl.edu.

PubMed
Summary

Deep brain stimulation (DBS) for Parkinson's disease (PD) requires careful patient selection and advanced programming. Innovations in hardware and programming offer personalized, efficient therapies for improved outcomes.